US ETFDetailed Quotes
XPH Spdr Series Trust Spdr S&P Pharmaceuticals Etf
- 43.490
- -0.550-1.25%
Close Dec 27 16:00 ET
44.020High43.350Low
44.020High43.350Low13.29KVolume43.770Open44.040Pre Close578.30KTurnover0.37%Turnover Ratio--P/E (Static)3.60MShares48.58652wk High--P/B156.58MFloat Cap38.42452wk Low0.68Dividend TTM3.60MShs Float57.735Historical High1.56%Div YieldTTM1.52%Amplitude20.630Historical Low43.507Avg Price1Lot Size
$Invesco Pharmaceuticals ETF (PJP.US)$ $Ishares Trust U.S. Pharmaceuticals Etf (IHE.US)$ $Spdr Series Trust Spdr S&P Pharmaceuticals Etf (XPH.US)$
$SPDR S&P Biotech ETF (XBI.US)$ $VanEck Biotech ETF (BBH.US)$
The price action of BMY is finding support near the 47.50 price point. It appears to be forming a double bottom on the charts so far.
There is a bullish divergence on several of the popular oscillating indicators for the weekly candles. The major indicators for the daily candles, like RSI and MACD, are all officially in bullish territory.
Ultimately, the price would need to climb out of the trading ...
From Worst to First?
The worst performing sector year-to-date was the best performing sector today after the CPI data release. The regional banking sector was hit especially hard this year.
Smaller bank’s capital ratios came into question earlier this year when large outflows of deposits hit a few regional banks. This caused a banking scare and a big selloff in the bank related ETFs. Smaller, more...
$AbbVie (ABBV.US)$: AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
$Protagonist Therapeutics (PTGX.US)$: Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis
$PTC Therapeutics (PTCT.US)$: Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022
$Scholar Rock (SRRK.US)$: Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
Follow for more insights and top news for pharmacy industry!
No comment yet